Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin
- 30 September 1996
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 26 (1) , 17-21
- https://doi.org/10.1016/s0732-8893(96)00146-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococciAntimicrobial Agents and Chemotherapy, 1995
- Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United StatesDiagnostic Microbiology and Infectious Disease, 1995
- Susceptibility of ciprofloxacin-resistant Staphylococci and Enterococci to clinafloxacinDiagnostic Microbiology and Infectious Disease, 1995
- Preliminary interpretive criteria for in vitro susceptibility testing of CP-99219 by dilution and disk diffusion methodsDiagnostic Microbiology and Infectious Disease, 1994
- Genetics and mechanisms of glycopeptide resistance in enterococciAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strainsDiagnostic Microbiology and Infectious Disease, 1992
- Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureusThe Journal of Infectious Diseases, 1991
- Increasing resistance of Staphylococcus aureus to ciprofloxacinAntimicrobial Agents and Chemotherapy, 1990